首页 > 最新文献

Neuro-Ophthalmology最新文献

英文 中文
Proceedings of the 45th Annual Upper Midwest Neuro-Ophthalmology Group Meeting, 21 July 2023 第45届上中西部神经眼科年会论文集,2023年7月21日
Q3 Medicine Pub Date : 2023-09-15 DOI: 10.1080/01658107.2023.2255664
Minjun Hur, Nanthaya Tisavipat, Collin M. McClelland, John Chen
{"title":"Proceedings of the 45th Annual Upper Midwest Neuro-Ophthalmology Group Meeting, 21 July 2023","authors":"Minjun Hur, Nanthaya Tisavipat, Collin M. McClelland, John Chen","doi":"10.1080/01658107.2023.2255664","DOIUrl":"https://doi.org/10.1080/01658107.2023.2255664","url":null,"abstract":"","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135397266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Idebenone Treatment in Patients with OPA1-Dominant Optic Atrophy: A Prospective Phase 2 Trial 依地苯酮治疗opa1显性视神经萎缩:一项前瞻性2期试验
Q3 Medicine Pub Date : 2023-09-14 DOI: 10.1080/01658107.2023.2251575
Katharina Valentin, Thomas Georgi, Regina Riedl, Haleh Aminfar, Christoph Singer, Thomas Klopstock, Andreas Wedrich, Mona Schneider
ABSTRACTThe aim of this study was to evaluate the therapeutic effect of idebenone in patients with OPA1-dominant optic atrophy (DOA). Sixteen patients with genetically confirmed OPA1-DOA were treated with 900 mg idebenone daily for 12 months. The primary endpoint was the best recovery/least deterioration of visual acuity. Secondary endpoints were the changes of visual acuity, colour vision, contrast sensitivity, visual field, peripapillary retinal nerve fibre layer thickness (pRNFLT), and visual-related quality of life. For the primary endpoint, a significant increase was observed for the right eye (p = .0027), for the left eye (p = .0111) and for the better-seeing eye (p = .0152). For visual fields, a significant improvement was observed for the left eye between baseline and 9 months (p = .0038). Regarding pRNFLT, a significant decrease was found for the left eye between baseline and 3 months (p = .0413) and between baseline and 6 months (p = .0448). In the visual function questionnaire, a significant improvement was observed in the subscale general vision (p = .0156) and in the composite score (p = .0256). In conclusion, best recovery of visual acuity improved, even though the amount of improvement was small. Furthermore, a maintenance of visual function after 12 months of idebenone intake could be observed as well as a significant improvement in vision-related quality of life.Whether this effect is due to idebenone treatment, the placebo effect, or is explainable by the natural progression of DOA, remains unclear.Trial registration: EU Clinical Trials Register, EudraCT Number: 2019-001493-28KEYWORDS: Dominant optic atrophyOPA1idebenoneoptic neuropathyvisual function AcknowledgementsThe authors thank all patients for their participation in this study.Disclosure statementK. Valentin received travel reimbursements from Chiesi Pharmaceuticals GmbH, H. Aminfar received travel reimbursements from Santhera Pharmaceuticals and Chiesi Pharmaceuticals GmbH. T. Klopstock received travel reimbursements and speaker honoraria from Santhera Pharmaceuticals and Chiesi Pharmaceuticals GmbH and M. Schneider received speaker honoraria from Santhera Pharmaceuticals. T. Georgi, R. Riedl, C. Singer, and A. Wedrich report no competing interests.Additional informationFundingThis work was supported by Chiesi Pharmaceuticals GmbH by a project-related grant for monitoring, pregnancy tests, registration fees, and patients’ insurance, as well as provision of study medication free of charge.
摘要本研究旨在评价依地苯酮对opa1显性视神经萎缩(DOA)患者的治疗效果。16例基因证实为OPA1-DOA的患者接受每日900毫克伊地苯酮治疗,持续12个月。主要终点为视力恢复最佳/视力恶化最小。次要终点是视力、色觉、对比敏感度、视野、乳头周围视网膜神经纤维层厚度(pRNFLT)和视觉相关生活质量的变化。对于主要终点,观察到右眼(p = 0.0027)、左眼(p = 0.0111)和视力较好的眼(p = 0.0152)的显著增加。在视野方面,左眼在基线至9个月期间有显著改善(p = 0.0038)。在pRNFLT方面,左眼在基线至3个月期间(p = 0.0413)和基线至6个月期间(p = 0.0448)显著下降。在视觉功能问卷中,一般视觉分量表和综合评分均有显著改善(p = 0.0156)。综上所述,视力的最佳恢复得到了改善,尽管改善的幅度很小。此外,在摄入伊地苯酮12个月后,可以观察到视觉功能的维持以及视觉相关生活质量的显着改善。这种影响是由于伊地苯酮治疗,安慰剂效应,还是由于DOA的自然进展,目前尚不清楚。试验注册:EU临床试验注册号:2019-001493-28关键词:显性视神经萎缩;非视神经病变;视觉功能披露statementK。Valentin收到了Chiesi Pharmaceuticals GmbH的差旅报销,H. Aminfar收到了Santhera Pharmaceuticals和Chiesi Pharmaceuticals GmbH的差旅报销。T. Klopstock从Santhera Pharmaceuticals和Chiesi Pharmaceuticals GmbH获得旅行报销和演讲酬金,M. Schneider从Santhera Pharmaceuticals获得演讲酬金。T. Georgi, R. Riedl, C. Singer和A. Wedrich报告没有利益竞争。本研究由Chiesi Pharmaceuticals GmbH提供项目相关资助,用于监测、妊娠测试、注册费和患者保险,并免费提供研究药物。
{"title":"Idebenone Treatment in Patients with OPA1-Dominant Optic Atrophy: A Prospective Phase 2 Trial","authors":"Katharina Valentin, Thomas Georgi, Regina Riedl, Haleh Aminfar, Christoph Singer, Thomas Klopstock, Andreas Wedrich, Mona Schneider","doi":"10.1080/01658107.2023.2251575","DOIUrl":"https://doi.org/10.1080/01658107.2023.2251575","url":null,"abstract":"ABSTRACTThe aim of this study was to evaluate the therapeutic effect of idebenone in patients with OPA1-dominant optic atrophy (DOA). Sixteen patients with genetically confirmed OPA1-DOA were treated with 900 mg idebenone daily for 12 months. The primary endpoint was the best recovery/least deterioration of visual acuity. Secondary endpoints were the changes of visual acuity, colour vision, contrast sensitivity, visual field, peripapillary retinal nerve fibre layer thickness (pRNFLT), and visual-related quality of life. For the primary endpoint, a significant increase was observed for the right eye (p = .0027), for the left eye (p = .0111) and for the better-seeing eye (p = .0152). For visual fields, a significant improvement was observed for the left eye between baseline and 9 months (p = .0038). Regarding pRNFLT, a significant decrease was found for the left eye between baseline and 3 months (p = .0413) and between baseline and 6 months (p = .0448). In the visual function questionnaire, a significant improvement was observed in the subscale general vision (p = .0156) and in the composite score (p = .0256). In conclusion, best recovery of visual acuity improved, even though the amount of improvement was small. Furthermore, a maintenance of visual function after 12 months of idebenone intake could be observed as well as a significant improvement in vision-related quality of life.Whether this effect is due to idebenone treatment, the placebo effect, or is explainable by the natural progression of DOA, remains unclear.Trial registration: EU Clinical Trials Register, EudraCT Number: 2019-001493-28KEYWORDS: Dominant optic atrophyOPA1idebenoneoptic neuropathyvisual function AcknowledgementsThe authors thank all patients for their participation in this study.Disclosure statementK. Valentin received travel reimbursements from Chiesi Pharmaceuticals GmbH, H. Aminfar received travel reimbursements from Santhera Pharmaceuticals and Chiesi Pharmaceuticals GmbH. T. Klopstock received travel reimbursements and speaker honoraria from Santhera Pharmaceuticals and Chiesi Pharmaceuticals GmbH and M. Schneider received speaker honoraria from Santhera Pharmaceuticals. T. Georgi, R. Riedl, C. Singer, and A. Wedrich report no competing interests.Additional informationFundingThis work was supported by Chiesi Pharmaceuticals GmbH by a project-related grant for monitoring, pregnancy tests, registration fees, and patients’ insurance, as well as provision of study medication free of charge.","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134910768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toxic Optic Neuropathy Due to Mercury in Skin Lightening Products 皮肤美白产品中汞引起的毒性视神经病变
Q3 Medicine Pub Date : 2023-09-14 DOI: 10.1080/01658107.2023.2251580
Richard N. Sather, Michael S. Lee
ABSTRACTMercury has been described as been in daily household items such as soaps, skin-lightening creams (SLC), and topical disinfectants. Mercury exposure can reportedly cause damage to the optic nerve and retina. A 30-year-old Somali woman presented with decreased vision and was found to have bilateral optic atrophy. Neuroimaging and laboratory work-up for nutritional deficiencies, heavy metals, and syphilis were performed. Evaluation revealed normal neuroimaging and laboratory work-up except for elevated serum and urine mercury levels. Mercury levels at the initial blood test was 11.1 ug/L (normal limits < 10.0 ug/L) and was 15.7 ug/L on repeat testing. A 24-h urine test showed elevated mercury at 16 ug/24 h (normal limits < 2 ug/24 h). Evaluation of an unlabelled SLC that she was using showed the presence of mercury. It is worth testing for heavy metals in the work-up of bilateral optic atrophy. Clinicians should consider cosmetic products as a potential source of mercury exposure and recommend discontinuation if mercury is present.KEYWORDS: Toxic optic neuropathymercury toxicityoptical coherence tomographyretinal nerve fibre layercosmetic products Disclosure statementNo potential conflict of interest was reported by the authors.Supplementary materialSupplemental data for this article can be accessed online at https://doi.org/10.1080/01658107.2023.2251580.Additional informationFundingThe authors reported there is no funding associated with the work featured in this article.
摘要汞被认为存在于日常生活用品中,如肥皂、美白面霜(SLC)和局部消毒剂。据报道,接触汞会对视神经和视网膜造成损害。一名30岁的索马里妇女表现为视力下降,并被发现有双侧视神经萎缩。进行了营养缺乏、重金属和梅毒的神经影像学和实验室检查。评估显示神经影像学和实验室检查正常,除了血清和尿汞水平升高。首次血液检测时汞含量为11.1微克/升(正常限值< 10.0微克/升),重复检测时为15.7微克/升。24小时尿检显示汞升高至16 ug/24小时(正常范围< 2 ug/24小时)。她使用的未标记SLC评估显示存在汞。在双侧视神经萎缩的检查中,有必要进行重金属检测。临床医生应将化妆品视为汞暴露的潜在来源,如果含有汞,应建议停用化妆品。关键词:中毒性视神经病变;汞毒性;光学相干断层扫描;视网膜神经纤维层;补充材料这篇文章的补充数据可以在网上访问https://doi.org/10.1080/01658107.2023.2251580.Additional信息基金作者报告没有与这篇文章的工作相关的资金。
{"title":"Toxic Optic Neuropathy Due to Mercury in Skin Lightening Products","authors":"Richard N. Sather, Michael S. Lee","doi":"10.1080/01658107.2023.2251580","DOIUrl":"https://doi.org/10.1080/01658107.2023.2251580","url":null,"abstract":"ABSTRACTMercury has been described as been in daily household items such as soaps, skin-lightening creams (SLC), and topical disinfectants. Mercury exposure can reportedly cause damage to the optic nerve and retina. A 30-year-old Somali woman presented with decreased vision and was found to have bilateral optic atrophy. Neuroimaging and laboratory work-up for nutritional deficiencies, heavy metals, and syphilis were performed. Evaluation revealed normal neuroimaging and laboratory work-up except for elevated serum and urine mercury levels. Mercury levels at the initial blood test was 11.1 ug/L (normal limits < 10.0 ug/L) and was 15.7 ug/L on repeat testing. A 24-h urine test showed elevated mercury at 16 ug/24 h (normal limits < 2 ug/24 h). Evaluation of an unlabelled SLC that she was using showed the presence of mercury. It is worth testing for heavy metals in the work-up of bilateral optic atrophy. Clinicians should consider cosmetic products as a potential source of mercury exposure and recommend discontinuation if mercury is present.KEYWORDS: Toxic optic neuropathymercury toxicityoptical coherence tomographyretinal nerve fibre layercosmetic products Disclosure statementNo potential conflict of interest was reported by the authors.Supplementary materialSupplemental data for this article can be accessed online at https://doi.org/10.1080/01658107.2023.2251580.Additional informationFundingThe authors reported there is no funding associated with the work featured in this article.","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134911341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical Coherence Tomography in a Morning Glory Disc Anomaly with a Peripapillary Choroidal Neovascular Membrane 牵牛花椎间盘异常伴乳突周围脉络膜新生血管膜的光学相干断层扫描
Q3 Medicine Pub Date : 2023-09-11 DOI: 10.1080/01658107.2023.2255665
Shikha Talwar Bassi, Aditya Verma
The purpose of this case report is to describe the optical coherence tomography (OCT) features of a peripapillary choroidal neovascular membrane (PPCNVM) in an eye with morning glory disc anomaly (MGDA). A PPCNVM appears as a hyper-reflective mass in the peripapillary area. It should be distinguished from peripapillary hyper-reflective ovoid mass-like structures, which are markers of axoplasmic flow stasis. This case report describes the distinguishing features between the two. The presence of intraretinal cystic spaces are indicative of an active PPCNVM. In conclusion, MGDA can be associated with PPCNVM and OCT can be used in its detection.
本病例报告的目的是描述具有牵牛花盘异常(MGDA)的眼睛的乳头周围脉络膜新生血管膜(PPCNVM)的光学相干断层扫描(OCT)特征。PPCNVM在乳头周围表现为高反射性肿块。它应与乳头周围高反射卵形肿块样结构区分开来,后者是轴浆血流停滞的标志。本病例报告描述了两者之间的区别特征。视网膜内囊性间隙的存在提示PPCNVM活跃。综上所述,MGDA可与PPCNVM相关联,OCT可用于PPCNVM的检测。
{"title":"Optical Coherence Tomography in a Morning Glory Disc Anomaly with a Peripapillary Choroidal Neovascular Membrane","authors":"Shikha Talwar Bassi, Aditya Verma","doi":"10.1080/01658107.2023.2255665","DOIUrl":"https://doi.org/10.1080/01658107.2023.2255665","url":null,"abstract":"The purpose of this case report is to describe the optical coherence tomography (OCT) features of a peripapillary choroidal neovascular membrane (PPCNVM) in an eye with morning glory disc anomaly (MGDA). A PPCNVM appears as a hyper-reflective mass in the peripapillary area. It should be distinguished from peripapillary hyper-reflective ovoid mass-like structures, which are markers of axoplasmic flow stasis. This case report describes the distinguishing features between the two. The presence of intraretinal cystic spaces are indicative of an active PPCNVM. In conclusion, MGDA can be associated with PPCNVM and OCT can be used in its detection.","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135938897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seizures as the Initial Manifestation of Idiopathic Intracranial Hypertension Spectrum Disorder 癫痫是特发性颅内高压谱障碍的初始表现
Q3 Medicine Pub Date : 2023-09-11 DOI: 10.1080/01658107.2023.2251579
Nisreen Al-Balushi, Walid Bouthour, Ana Banc, Rasha Mosleh, Amit M. Saindane, Nancy J. Newman, Valérie Biousse
ABSTRACT Idiopathic intracranial hypertension (IIH) is a syndrome of isolated elevated intracranial pressure of unknown aetiology. The IIH spectrum has evolved over the past decade making the diagnosis and management more challenging. The neurological examination in IIH is typically normal except for papilloedema and possible cranial nerve 6 palsy. Recent publications have highlighted skull base thinning and remodelling in patients with chronic IIH. Resulting skull base defects can cause meningo-encephalocoeles, which are potential epileptogenic foci. We describe the clinical and radiological characteristics of five IIH patients with seizures and meningo-encephalocoeles as the presenting manifestations of IIH spectrum disorder.
{"title":"Seizures as the Initial Manifestation of Idiopathic Intracranial Hypertension Spectrum Disorder","authors":"Nisreen Al-Balushi, Walid Bouthour, Ana Banc, Rasha Mosleh, Amit M. Saindane, Nancy J. Newman, Valérie Biousse","doi":"10.1080/01658107.2023.2251579","DOIUrl":"https://doi.org/10.1080/01658107.2023.2251579","url":null,"abstract":"ABSTRACT Idiopathic intracranial hypertension (IIH) is a syndrome of isolated elevated intracranial pressure of unknown aetiology. The IIH spectrum has evolved over the past decade making the diagnosis and management more challenging. The neurological examination in IIH is typically normal except for papilloedema and possible cranial nerve 6 palsy. Recent publications have highlighted skull base thinning and remodelling in patients with chronic IIH. Resulting skull base defects can cause meningo-encephalocoeles, which are potential epileptogenic foci. We describe the clinical and radiological characteristics of five IIH patients with seizures and meningo-encephalocoeles as the presenting manifestations of IIH spectrum disorder.","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135982247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disc-Oedema Toxoplasmosis. 椎间盘水肿弓形虫病。
IF 0.8 Q4 CLINICAL NEUROLOGY Pub Date : 2023-08-22 eCollection Date: 2023-01-01 DOI: 10.1080/01658107.2023.2242969
Parthopratim Dutta Majumder, Jyotirmay Biswas
{"title":"Disc-Oedema Toxoplasmosis.","authors":"Parthopratim Dutta Majumder, Jyotirmay Biswas","doi":"10.1080/01658107.2023.2242969","DOIUrl":"10.1080/01658107.2023.2242969","url":null,"abstract":"","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10735275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79789331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of Ophthalmological Evaluation in the Conservative Management of Increased Intracranial Pressure from a Ruptured Arachnoid Cyst. 眼科评估在蛛网膜囊肿破裂导致颅内压增高的保守治疗中的重要性。
IF 0.8 Q4 CLINICAL NEUROLOGY Pub Date : 2023-07-13 eCollection Date: 2024-01-01 DOI: 10.1080/01658107.2023.2228398
Rafael Lani-Louzada, Frederico Castelo Moura

Arachnoid cysts (ACs) are cerebrospinal fluid collections between the two layers of the normal arachnoid membrane. Although they are often asymptomatic with a stationary course, eventual complications may occur. Herein, we report the case of a 9-year-old boy who developed bilateral papilloedema secondary to spontaneous rupture of an AC in the left middle cranial fossa. Although the papilloedema worsened during follow-up, his visual field remained bilaterally stable, supporting the expectant management and obviating the potential morbidity associated with neurosurgical intervention. This case report highlights the importance of a multidisciplinary approach to patients with secondary intracranial hypertension, including serial ophthalmological examinations, which provide a useful guide to surgical decision-making.

蛛网膜囊肿(AC)是正常蛛网膜两层之间的脑脊液聚集。虽然蛛网膜囊肿通常无症状,病程稳定,但最终可能出现并发症。我们在此报告了一例 9 岁男孩的病例,他因左侧中颅窝的 AC 自发性破裂而继发双侧乳头水肿。虽然乳头水肿在随访期间有所恶化,但他的双侧视野仍然保持稳定,这支持了预期治疗,避免了神经外科干预可能带来的发病率。本病例报告强调了对继发性颅内高压患者采取多学科治疗方法的重要性,其中包括连续的眼科检查,这为手术决策提供了有用的指导。
{"title":"Importance of Ophthalmological Evaluation in the Conservative Management of Increased Intracranial Pressure from a Ruptured Arachnoid Cyst.","authors":"Rafael Lani-Louzada, Frederico Castelo Moura","doi":"10.1080/01658107.2023.2228398","DOIUrl":"10.1080/01658107.2023.2228398","url":null,"abstract":"<p><p>Arachnoid cysts (ACs) are cerebrospinal fluid collections between the two layers of the normal arachnoid membrane. Although they are often asymptomatic with a stationary course, eventual complications may occur. Herein, we report the case of a 9-year-old boy who developed bilateral papilloedema secondary to spontaneous rupture of an AC in the left middle cranial fossa. Although the papilloedema worsened during follow-up, his visual field remained bilaterally stable, supporting the expectant management and obviating the potential morbidity associated with neurosurgical intervention. This case report highlights the importance of a multidisciplinary approach to patients with secondary intracranial hypertension, including serial ophthalmological examinations, which provide a useful guide to surgical decision-making.</p>","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81724759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differentiating Occult Neuroretinitis and Non-Arteritic Anterior Ischaemic Optic Neuropathy: Clinical and Optical Coherence Tomography Characteristics. 区分隐匿性神经视网膜炎和非动脉性前部缺血性视神经病变:临床和光学相干断层扫描特征。
IF 0.8 Q4 CLINICAL NEUROLOGY Pub Date : 2023-07-07 eCollection Date: 2023-01-01 DOI: 10.1080/01658107.2023.2220778
Snehal Ganatra, Bhavik Panchal, Avinash Pathengay, Virender Sachdeva

We report clinical and optical coherence tomography (OCT) differences among patients with occult neuroretinitis and non-arteritic anterior ischaemic optic neuropathy (NAAION). We retrospectively reviewed records of patients with a final diagnosis of occult neuroretinitis and NAAION seen at our institute. Data were collected regarding patient demographics, clinical features, concomitant systemic risk factors, visual function, and optical coherence tomography (OCT) findings at presentation and subsequent follow-up. Fourteen and 16 patients were diagnosed to have occult neuroretinitis and NAAION, respectively. Patients with NAAION were slightly older (median age 49, inter-quartile range [IQR]: 45-54 years, versus 41, IQR: 31-50 years) than patients with neuroretinitis. Seventy-five per cent of patients with NAAION were male versus 43% with neuroretinitis (p = 0.07). Systemic risk factors were present in 87.5% of patients with NAAION versus 21.4% in patients with neuroretinitis (p = 0.001). At presentation, all patients presented with blurred vision, had similar visual function, and had optic disc oedema. In addition, none of the patients had evident retinitis lesions, but 10 (71%) showed evident retinitis lesion at follow-up. Neuroretinitis patients had more often vitreous cells (64% versus 6%, p = 0.001), and subretinal fluid (78.6% versus 37.5%, p = 0.03) than the patients with NAAION. In summary, NAAION patients tended to be slightly older, more often male, and had associated systemic diseases more often than those with neuroretinitis. Neuroretinitis patients more often had posterior vitreous cells and subretinal fluid on OCT. However, larger prospective studies are needed.

我们报告了隐匿性神经视网膜炎和非动脉性前缺血性视神经病变(NAION)患者的临床和光学相干断层扫描(OCT)差异。我们回顾性地回顾了在我们研究所看到的最终诊断为隐匿性神经视网膜炎和NAION的患者的记录。收集了患者人口统计学、临床特征、伴随的全身危险因素、视觉功能和光学相干断层扫描(OCT)检查结果的数据。14名和16名患者分别被诊断为隐匿性神经视网膜炎和NAION。NAION患者比神经视网膜炎患者年龄稍大(中位年龄49岁,四分位间距[IQR]:45-54岁,而41岁,IQR:31-50岁)。75%的NAION患者为男性,43%的患者为神经性视网膜炎(p=0.07)。87.5%的NAATION患者存在系统风险因素,21.4%的患者存在神经性视网膜病(p=0.001)。所有患者在出现时都表现为视力模糊、视觉功能相似和视盘水肿。此外,没有一名患者有明显的视网膜炎病变,但在随访中有10名(71%)患者有明显视网膜炎病变。神经视网膜炎患者的玻璃体细胞(64%对6%,p=0.001)和视网膜下液(78.6%对37.5%,p=0.03)的发生率高于NAION患者。总之,NAION患者往往年龄稍大,更常见的是男性,并且比神经视网膜炎患者更常见相关的系统性疾病。神经视网膜炎患者在OCT上更常见的是后玻璃体细胞和视网膜下液。然而,还需要更大规模的前瞻性研究。
{"title":"Differentiating Occult Neuroretinitis and Non-Arteritic Anterior Ischaemic Optic Neuropathy: Clinical and Optical Coherence Tomography Characteristics.","authors":"Snehal Ganatra, Bhavik Panchal, Avinash Pathengay, Virender Sachdeva","doi":"10.1080/01658107.2023.2220778","DOIUrl":"10.1080/01658107.2023.2220778","url":null,"abstract":"<p><p>We report clinical and optical coherence tomography (OCT) differences among patients with occult neuroretinitis and non-arteritic anterior ischaemic optic neuropathy (NAAION). We retrospectively reviewed records of patients with a final diagnosis of occult neuroretinitis and NAAION seen at our institute. Data were collected regarding patient demographics, clinical features, concomitant systemic risk factors, visual function, and optical coherence tomography (OCT) findings at presentation and subsequent follow-up. Fourteen and 16 patients were diagnosed to have occult neuroretinitis and NAAION, respectively. Patients with NAAION were slightly older (median age 49, inter-quartile range [IQR]: 45-54 years, versus 41, IQR: 31-50 years) than patients with neuroretinitis. Seventy-five per cent of patients with NAAION were male versus 43% with neuroretinitis (<i>p</i> = 0.07). Systemic risk factors were present in 87.5% of patients with NAAION versus 21.4% in patients with neuroretinitis (<i>p</i> = 0.001). At presentation, all patients presented with blurred vision, had similar visual function, and had optic disc oedema. In addition, none of the patients had evident retinitis lesions, but 10 (71%) showed evident retinitis lesion at follow-up. Neuroretinitis patients had more often vitreous cells (64% versus 6%, <i>p</i> = 0.001), and subretinal fluid (78.6% versus 37.5%, <i>p</i> = 0.03) than the patients with NAAION. In summary, NAAION patients tended to be slightly older, more often male, and had associated systemic diseases more often than those with neuroretinitis. Neuroretinitis patients more often had posterior vitreous cells and subretinal fluid on OCT. However, larger prospective studies are needed.</p>","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9815287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Presentation of Ocular Syphilis with Bilateral Optic Neuropathy. 眼部梅毒并发双侧视神经病变。
IF 0.8 Q4 CLINICAL NEUROLOGY Pub Date : 2023-07-05 eCollection Date: 2023-01-01 DOI: 10.1080/01658107.2023.2222800
Mustafa Kayabaşı, Seher Köksaldı, Ali Osman Saatci, Meltem Söylev Bajin

A 60-year-old otherwise healthy male presented with a 1 year history of bilateral progressive visual loss. His best-corrected visual acuity was counting fingers at 2 m with his right eye and counting fingers at 0.5 m with his left eye. Visual field testing revealed bilateral near-total loss of visual fields. Slit-lamp examination was unremarkable, apart from bilateral grade two nuclear sclerotic cataracts. Both optic discs were pale-looking with some retinal pigment epithelial alterations at the left papillomacular region. Enhanced depth imaging optical coherence tomography depicted punctate hyperreflective dots at the inner choroidal level corresponding to the retinal pigment epithelial changes in the left eye. Fundus autofluorescence imaging revealed patchy hyper-autofluorescent and hypo-autofluorescent areas, and there was mild staining in the early and late phases of the fluorescein angiogram at the papillomacular region in the left eye. A diagnosis of bilateral optic neuropathy was made. A full systemic work-up was carried out, and serological tests pointed out the presence of syphilis with normal cranial magnetic resonance imaging. He was treated accordingly. Our case clearly demonstrates the importance of a high clinical suspicion for syphilis in cases of optic neuropathy.

一名 60 岁、身体健康的男性患者出现双侧进行性视力下降,病史已有 1 年。他的最佳矫正视力为右眼在 2 米处数手指,左眼在 0.5 米处数手指。视野测试显示双侧视野接近完全丧失。裂隙灯检查除了双侧二级核硬化性白内障外,没有其他异常。双侧视盘外观苍白,左侧乳头状区有一些视网膜色素上皮改变。增强深度成像光学相干断层扫描显示,左眼视网膜色素上皮病变对应的脉络膜内层有点状高反射点。眼底自发荧光成像显示斑片状高自发荧光区和低自发荧光区,左眼乳头黄斑区荧光素血管造影早期和晚期有轻度染色。诊断结果为双侧视神经病变。对他进行了全面的全身检查,血清学检测显示存在梅毒,头颅磁共振成像正常。他接受了相应的治疗。我们的病例清楚地表明,临床上高度怀疑梅毒对视神经病变的重要性。
{"title":"Presentation of Ocular Syphilis with Bilateral Optic Neuropathy.","authors":"Mustafa Kayabaşı, Seher Köksaldı, Ali Osman Saatci, Meltem Söylev Bajin","doi":"10.1080/01658107.2023.2222800","DOIUrl":"10.1080/01658107.2023.2222800","url":null,"abstract":"<p><p>A 60-year-old otherwise healthy male presented with a 1 year history of bilateral progressive visual loss. His best-corrected visual acuity was counting fingers at 2 m with his right eye and counting fingers at 0.5 m with his left eye. Visual field testing revealed bilateral near-total loss of visual fields. Slit-lamp examination was unremarkable, apart from bilateral grade two nuclear sclerotic cataracts. Both optic discs were pale-looking with some retinal pigment epithelial alterations at the left papillomacular region. Enhanced depth imaging optical coherence tomography depicted punctate hyperreflective dots at the inner choroidal level corresponding to the retinal pigment epithelial changes in the left eye. Fundus autofluorescence imaging revealed patchy hyper-autofluorescent and hypo-autofluorescent areas, and there was mild staining in the early and late phases of the fluorescein angiogram at the papillomacular region in the left eye. A diagnosis of bilateral optic neuropathy was made. A full systemic work-up was carried out, and serological tests pointed out the presence of syphilis with normal cranial magnetic resonance imaging. He was treated accordingly. Our case clearly demonstrates the importance of a high clinical suspicion for syphilis in cases of optic neuropathy.</p>","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10732629/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82015129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinically Diagnosed Occult Macular Dystrophy Habouring an m.14502T>C Mitochondrial DNA Mutation Associated with Leber's Hereditary Optic Neuropathy: Case Report and Literature Review. 临床诊断为隐性黄斑营养不良,伴有 m.14502T>C 线粒体 DNA 突变,与 Leber 遗传性视神经病变有关:病例报告和文献综述。
IF 0.8 Q4 CLINICAL NEUROLOGY Pub Date : 2023-07-05 eCollection Date: 2023-01-01 DOI: 10.1080/01658107.2023.2231077
Han Peng Zhou, Hiromasa Sawamura, Natsuko Nakamura, Akiko Yamagami, Ryoma Yasumoto, Kyoko Kasai, Ryo Obata, Makoto Aihara

A 29-year-old female with no family history presented with bilateral progressive blurred vision. Her symptoms appeared at 12-years-old and her visual acuity had since deteriorated from 0.6 to 0.2 bilaterally with decreased critical flicker frequency and bilateral central scotomas. She did not have a relative afferent pupillary defect. Fundoscopy revealed no distinct disc hyperaemia, atrophy, or peripapillary telangiectatic vessels. The retinal nerve fibre layer appeared normal on optical coherence tomography in each eye; however, loss of the interdigitation zone and the disruption of the ellipsoid zone at the fovea were observed in both eyes. Multifocal electroretinography revealed decreased amplitudes at both macula regions. Mitochondrial deoxyribonucleic acid analysis identified an m.14502T>C mutation, one of the primary mutations causing Leber's hereditary optic neuropathy (LHON). Despite the presence of a marked LHON mutation, however, she was clinically diagnosed as having an occult macular dystrophy. There have only been five previous case reports, all of which were sporadic, which detail the clinical characteristics of the m.14502T>C mutation. The m.14502T>C phenotype is somewhat consistent with that of the other major mutations, including young onset, bilateral progressive visual impairment, and a typical LHON fundus. Nevertheless, m.14502T>C alone has an extremely low penetrance and its phenotype may be minimal or subclinical, as seen in our case. Since little is known about the clinical course of the m.14502T>C mutation it may be possible that the LHON phenotype may appear in later stages of life. Moreover, m.14502T>C may function as a modifier gene, which alters the phenotype of other coexisting major LHON mutations, including penetrance and the severity of the disease, through synergistic effects.

一名无家族史的 29 岁女性因双侧进行性视力模糊前来就诊。她的症状出现于 12 岁,视力从 0.6 下降到 0.2,临界闪烁频率降低,并伴有双侧中心性焦斑。她没有相对的瞳孔传入缺陷。眼底镜检查未发现明显的视盘高血、萎缩或毛细血管扩张。两只眼睛的视网膜神经纤维层在光学相干断层扫描中均显示正常,但在两只眼睛中均观察到交织区的消失和眼窝处椭圆区的破坏。多灶视网膜电图显示,两只眼睛黄斑区的振幅都有所下降。线粒体脱氧核糖核酸分析发现了m.14502T>C突变,这是导致勒伯遗传性视神经病变(LHON)的主要突变之一。尽管存在明显的 LHON 突变,但临床诊断她患有隐性黄斑营养不良症。此前仅有五例病例报告详细描述了m.14502T>C突变的临床特征,这些病例均为散发性。m.14502T>C 的表型与其他主要突变的表型有些一致,包括年轻发病、双侧进行性视力损害和典型的 LHON 眼底。尽管如此,m.14502T>C 本身的渗透率极低,其表型可能极小或亚临床,就像我们的病例一样。由于对 m.14502T>C 基因突变的临床过程知之甚少,因此 LHON 表型有可能出现在生命的晚期。此外,m.14502T>C 可能是一个修饰基因,通过协同作用改变其他共存的主要 LHON 基因突变的表型,包括渗透性和疾病的严重程度。
{"title":"Clinically Diagnosed Occult Macular Dystrophy Habouring an m.14502T>C Mitochondrial DNA Mutation Associated with Leber's Hereditary Optic Neuropathy: Case Report and Literature Review.","authors":"Han Peng Zhou, Hiromasa Sawamura, Natsuko Nakamura, Akiko Yamagami, Ryoma Yasumoto, Kyoko Kasai, Ryo Obata, Makoto Aihara","doi":"10.1080/01658107.2023.2231077","DOIUrl":"10.1080/01658107.2023.2231077","url":null,"abstract":"<p><p>A 29-year-old female with no family history presented with bilateral progressive blurred vision. Her symptoms appeared at 12-years-old and her visual acuity had since deteriorated from 0.6 to 0.2 bilaterally with decreased critical flicker frequency and bilateral central scotomas. She did not have a relative afferent pupillary defect. Fundoscopy revealed no distinct disc hyperaemia, atrophy, or peripapillary telangiectatic vessels. The retinal nerve fibre layer appeared normal on optical coherence tomography in each eye; however, loss of the interdigitation zone and the disruption of the ellipsoid zone at the fovea were observed in both eyes. Multifocal electroretinography revealed decreased amplitudes at both macula regions. Mitochondrial deoxyribonucleic acid analysis identified an m.14502T>C mutation, one of the primary mutations causing Leber's hereditary optic neuropathy (LHON). Despite the presence of a marked LHON mutation, however, she was clinically diagnosed as having an occult macular dystrophy. There have only been five previous case reports, all of which were sporadic, which detail the clinical characteristics of the m.14502T>C mutation. The m.14502T>C phenotype is somewhat consistent with that of the other major mutations, including young onset, bilateral progressive visual impairment, and a typical LHON fundus. Nevertheless, m.14502T>C alone has an extremely low penetrance and its phenotype may be minimal or subclinical, as seen in our case. Since little is known about the clinical course of the m.14502T>C mutation it may be possible that the LHON phenotype may appear in later stages of life. Moreover, m.14502T>C may function as a modifier gene, which alters the phenotype of other coexisting major LHON mutations, including penetrance and the severity of the disease, through synergistic effects.</p>","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10732632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75367003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neuro-Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1